Ondine Biomedical Inc. (LON:OBI – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 5.50 ($0.07) and last traded at GBX 5.88 ($0.07), with a volume of 431829 shares changing hands. The stock had previously closed at GBX 6.25 ($0.08).
Ondine Biomedical Stock Down 6.0 %
The company has a debt-to-equity ratio of 24.39, a quick ratio of 8.26 and a current ratio of 2.34. The stock has a market cap of £13.32 million, a P/E ratio of -97.92 and a beta of -0.14. The stock’s fifty day simple moving average is GBX 8.84 and its 200-day simple moving average is GBX 9.35.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- Conference Calls and Individual Investors
- Hasbro’s Management Made All the Right Calls This Quarter
- Business Services Stocks Investing
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- What Investors Need to Know About Upcoming IPOs
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
